Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_assertion type Assertion NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_head.
- NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_assertion description "[Recently published or communicated clinical experiences and ongoing trials have used defined tumor antigen RNA transfection for prostate carcinoma and melanoma, liposome-encoated DNA transfection for breast or pancreatic cancer, adenoviral vector tumor antigen gene modification for melanoma and small cell lung cancer, and poxvirus-mediated expression of costimulatory molecules for colon carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_provenance.
- NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_assertion evidence source_evidence_literature NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_provenance.
- NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_assertion SIO_000772 16457651 NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_provenance.
- NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_assertion wasDerivedFrom befree-20140225 NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_provenance.
- NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_assertion wasGeneratedBy ECO_0000203 NP664605.RAwRSdfsEQ-MxHK2ba0H7stAJAbTNlaH4DMAAqy1d4AcQ130_provenance.